Adma Biologics Inc’s recent filing unveils that its Director Guiheen Lawrence P. unloaded Company’s shares for reported $0.16 million on May 21 ’25. In the deal valued at $20.32 per share,7,779 shares were sold. As a result of this transaction, Guiheen Lawrence P. now holds 114,830 shares worth roughly $2.35 million.
Then, Guiheen Lawrence P. sold 1,221 shares, generating $24,567 in total proceeds. Upon selling the shares at $20.12, the Director now owns 114,830 shares.
Before that, Guiheen Lawrence P. bought 9,000 shares. Adma Biologics Inc shares valued at $183,960 were divested by the Director at a price of $20.44 per share.
A number of analysts have revised their coverage, including Mizuho’s analysts, who began to cover the stock in mid October with a ‘”a Buy”‘ rating. Raymond James also remained covering ADMA and has increased its forecast on November 11, 2021 with a “Strong buy” recommendation from previously “an Outperform” rating. Cantor Fitzgerald started covering the stock on November 09, 2021. It rated ADMA as “an Overweight”.
Price Performance Review of ADMA
On Tuesday, Adma Biologics Inc [NASDAQ:ADMA] saw its stock jump 0.15% to $20.46. Over the last five days, the stock has gained 2.87%. Adma Biologics Inc shares have risen nearly 19.30% since the year began. Nevertheless, the stocks have risen 115.82% over the past one year. While a 52-week high of $25.67 was reached on 04/28/25, a 52-week low of $9.63 was recorded on 03/04/25. SMA at 50 days reached $20.70, while 200 days put it at $18.68.
Levels Of Support And Resistance For ADMA Stock
The 24-hour chart illustrates a support level at 20.19, which if violated will result in even more drops to 19.91. On the upside, there is a resistance level at 20.68. A further resistance level may holdings at 20.89. The Relative Strength Index (RSI) on the 14-day chart is 49.81, which indicates neutral technical sentiment, while the Moving Average Convergence Divergence (MACD) stands at 0.27, which suggests price will go down in the next trading period. Percent R suggests that price movement has been bullish at 15.17%. Stochastics %K at 70.81% indicates the stock is a holding.
How much short interest is there in Adma Biologics Inc?
A steep rise in short interest was recorded in Adma Biologics Inc stocks on 2025-05-15, growing by 77071.0 shares to a total of 13.33 million shares. Yahoo Finance data shows the prior-month short interest on 2025-04-15 was 13.26 million shares. There was a rise of 0.58%, which implies that there is a positive sentiment for the stock.
The most recent change occurred on June 04, 2019 when Jefferies began covering the stock and recommended ‘”a Buy”‘ rating along with a $8 price target.
